Month: July 2012
Not All HIV Patients in U.S. Show Same Characteristics: Study
SUNDAY, July 22 (HealthDay News) — Among people with HIV in the United States, those born outside the country are more likely than U.S.-born patients to be Hispanic or Asian and to have acquired HIV through heterosexual sex, a new study finds.
‘Toe-Walking’ More Common in Kids With Mental Woes: Study
MONDAY, July 23 (HealthDay News) — As many as one in 20 children may predominantly walk on their toes in early childhood. Youngsters who have developmental delays or neuropsychiatric disorders, however, are more likely to walk on their toes, according to a new study from Sweden.
Pre-Season Fitness Not a Factor in Collegiate Sports Injury Risk
Mom’s HIV Drugs May Pass to Baby in Womb, Breast-Feeding
SATURDAY, July 21 (HealthDay News) — Babies born to HIV-positive women taking antiretroviral drugs to fight the disease may become exposed to the drugs in the womb and during breast-feeding, new research shows.
Women With HIV May Not Have Higher Cervical Cancer Risk: Study
MONDAY, July 23 (HealthDay News) — Infection with HIV — the virus that causes AIDS — does not appear to increase a woman’s risk of cervical cancer, a new study has found.
Health Tip: Buying Shoes for Your Child
(HealthDay News) — A child’s feet can grow rapidly, so don’t ever assume that your child still needs the same shoe size as last time.
Health Tip: Do You Need a Day Off From Exercise?
(HealthDay News) — While exercise can help you feel better physically and emotionally, it may be wise to skip a day if you aren’t feeling well.
New SEEDS Supplier Added to Premier’s Physical Therapy Products and Exercise Equipment Portfolio
The Premier healthcare alliance today announced that a new SEEDS™ agreement for physical therapy products and exercise equipment has been awarded to Physical Enterprise Inc., a sma
Illumina countersues IBS and Qiagen
(Reuters) – Genetic sequencing company Illumina Inc countersued Intelligent Bio-Systems Inc and Qiagen NV alleging infringement on three of its patents expiring in December 2022. Illumina alleged infringement on patents that are applicable to the “sequencing by synthesis technology” being used in the IBS Max-Seq and MINI-20 DNA Sequencers. The company said the suit was in response to the lawsuit brought against Illumina in March by Columbia University and IBS alleging infringement of five patents related to DNA sequencing. Qiagen acquired IBS in June. …
Bayer says Nexavar-Tarceva trial unsuccessful
(Reuters) – The combination of cancer tablets Tarceva and Nexavar to treat patients with liver cancer failed to improve overall survival rates compared with standard Nexavar treatment in a late-stage Phase III trial, drug companies involved said on Monday. Analysts at brokerage Cheuvreux said the news was a small negative for Bayer AG , the lead partner in the trial, but they left peak sales forecasts for Nexavar unchanged at 971 million euros ($1.18 billion) in 2019. …